These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 30572925)
1. A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke. Huang Q; Zhong W; Hu Z; Tang X J Neuroinflammation; 2018 Dec; 15(1):348. PubMed ID: 30572925 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of caveolin-1 attenuates brain edema by inhibiting tight junction degradation. Choi KH; Kim HS; Park MS; Lee EB; Lee JK; Kim JT; Kim JH; Lee MC; Lee HJ; Cho KH Oncotarget; 2016 Oct; 7(42):67857-67867. PubMed ID: 27708218 [TBL] [Abstract][Full Text] [Related]
3. Regulation of Caveolin-1 Expression Determines Early Brain Edema After Experimental Focal Cerebral Ischemia. Choi KH; Kim HS; Park MS; Kim JT; Kim JH; Cho KA; Lee MC; Lee HJ; Cho KH Stroke; 2016 May; 47(5):1336-43. PubMed ID: 27012742 [TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835 [TBL] [Abstract][Full Text] [Related]
6. Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke. Lv J; Hu W; Yang Z; Li T; Jiang S; Ma Z; Chen F; Yang Y Prog Neurobiol; 2018 Feb; 161():79-96. PubMed ID: 29217457 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection. Trevino TN; Almousawi AA; Robinson KF; Fogel AB; Class J; Minshall RD; Tai LM; Richner JM; Lutz SE J Neuroimmunol; 2024 Mar; 388():578309. PubMed ID: 38335781 [TBL] [Abstract][Full Text] [Related]
8. Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery. Chen HS; Chen X; Li WT; Shen JG Acta Pharmacol Sin; 2018 May; 39(5):669-682. PubMed ID: 29595191 [TBL] [Abstract][Full Text] [Related]
9. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Gu Y; Dee CM; Shen J Front Biosci (Schol Ed); 2011 Jun; 3(4):1216-31. PubMed ID: 21622267 [TBL] [Abstract][Full Text] [Related]
10. Role of caveolin-1/vascular endothelial growth factor pathway in basic fibroblast growth factor-induced angiogenesis and neurogenesis after treadmill training following focal cerebral ischemia in rats. Pang Q; Zhang H; Chen Z; Wu Y; Bai M; Liu Y; Zhao Y; Tu F; Liu C; Chen X Brain Res; 2017 May; 1663():9-19. PubMed ID: 28300551 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-103-3p Preserves Neurovascular Integrity Through Caveolin-1 in Experimental Subarachnoid Hemorrhage. Wang L; Zhao Y; Gang S; Geng T; Li M; Xu L; Zhang X; Liu L; Xie Y; Ye R; Liu X Neuroscience; 2021 May; 461():91-101. PubMed ID: 33722672 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 in Stroke Neuropathology and Neuroprotection: A Novel Molecular Therapeutic Target for Ischemic-Related Injury. Wang S; Head BP Curr Vasc Pharmacol; 2019; 17(1):41-49. PubMed ID: 29412114 [TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier dysfunction and recovery after ischemic stroke. Jiang X; Andjelkovic AV; Zhu L; Yang T; Bennett MVL; Chen J; Keep RF; Shi Y Prog Neurobiol; 2018; 163-164():144-171. PubMed ID: 28987927 [TBL] [Abstract][Full Text] [Related]
14. Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood-Brain Barrier Permeability During Early Reperfusion in Stroke. Zhang S; An Q; Wang T; Gao S; Zhou G Neuroscience; 2018 May; 377():126-137. PubMed ID: 29524637 [TBL] [Abstract][Full Text] [Related]
15. Caveolin expression changes in the neurovascular unit after juvenile traumatic brain injury: signs of blood-brain barrier healing? Badaut J; Ajao DO; Sorensen DW; Fukuda AM; Pellerin L Neuroscience; 2015 Jan; 285():215-26. PubMed ID: 25450954 [TBL] [Abstract][Full Text] [Related]
16. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke. Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273 [TBL] [Abstract][Full Text] [Related]
17. The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis. Kraft P; Schwarz T; Göb E; Heydenreich N; Brede M; Meuth SG; Kleinschnitz C Exp Neurol; 2013 Sep; 247():80-90. PubMed ID: 23570902 [TBL] [Abstract][Full Text] [Related]
18. Electroacupuncture preconditioning reduces ROS generation with NOX4 down-regulation and ameliorates blood-brain barrier disruption after ischemic stroke. Jung YS; Lee SW; Park JH; Seo HB; Choi BT; Shin HK J Biomed Sci; 2016 Mar; 23():32. PubMed ID: 26952102 [TBL] [Abstract][Full Text] [Related]
19. Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Nag S; Manias JL; Stewart DJ Neuropathol Appl Neurobiol; 2009 Aug; 35(4):417-426. PubMed ID: 19508446 [TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 and MLRs: A potential target for neuronal growth and neuroplasticity after ischemic stroke. Zhong W; Huang Q; Zeng L; Hu Z; Tang X Int J Med Sci; 2019; 16(11):1492-1503. PubMed ID: 31673241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]